Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RadioEmbolization for the ADvancement of Y90 Glass Microspheres Registry

NCT03516695 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT03516695
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03516695 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RadioEmbolization for the ADvancement of Y90 Glass Microspheres Registry
Lead sponsor
Boston Scientific Corporation
Phase
Observational
Overall status
Terminated
Start date
February 23, 2018
Completion date
December 12, 2018
Enrollment
95 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer